Cell and Gene Therapy Clinical Trials Market to Soar on Back of Rising Oncology Programs, Rare Disease Focus, and Personalized Medicine Expansion
The global cell and gene therapy clinical trials market, valued at USD 10.72 billion in 2024, is projected to grow at a CAGR of 15.4% from 2025 to 2034, reaching an estimated USD 44.83 billion by 2034. The surge is driven by an expanding pipeline of gene-modified cell therapies, rapid progress in personalized medicine, and strong investment from both...
0 Comments 0 Shares 5 Views 0 Reviews